Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs

Heineken has issued a warning to British pubs and bars regarding the potential impact of weight-loss medications, such as Wegovy, on alcohol consumption. The brewer suggests that the increasing popularity of these drugs may lead to a decline in the sales of beer and cider, as users may experience a reduced desire to consume alcohol.

This assessment, contained within internal company documentation, highlights concerns among major beverage producers regarding shifting consumer habits linked to pharmaceutical weight-loss trends. The warning underscores the potential for these drugs to influence broader market dynamics within the hospitality and alcohol sectors.